Sato, Sho
Gillette, Michael
de Santiago, Pamela R.
Kuhn, Eric
Burgess, Michael
Doucette, Kristen
Feng, Yi
Mendez-Dorantes, Carlos
Ippoliti, Paul J.
Hobday, Sara
Mitchell, Marilyn A.
Doberstein, Kai
Gysler, Stefan M.
Hirsch, Michelle S.
Schwartz, Lauren
Birrer, Michael J.
Skates, Steven J.
Burns, Kathleen H.
Carr, Steven A.
Drapkin, Ronny
Funding for this research was provided by:
Claneil Foundation
National Institutes of Health (5U01CA152990)
Helene Ross Bogutz Fund for Ovarian Cancer Early Detection
Mike and Patti Hennessy Foundation
Ovarian Cancer Research Alliance (891470)
China Scholarship Council
Honorable Tina Brozman Foundation
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Shooting for a Cure
Deutsche Forschungsgemeinschaft
Rivkin Center for Ovarian Cancer (Skacel Family Scientific Scholar Award)
Marjorie S. Stanek and Lowell H. Dubrow Ovarian Cancer Research Center Endowed Fund
Maggie’s Memorial Fund
Article History
Received: 16 August 2022
Accepted: 25 January 2023
First Online: 27 January 2023
Competing interests
: R. Drapkin serves on the scientific advisory board of Repare Therapeutics and VOC Health. None of the other authors declare any competing interests.